InvestorsHub Logo

sello

12/27/22 6:06 PM

#149275 RE: sello #149274

Looks like there may be a covid link with this patent. There are other patent applications using klotho to treat covid symptoms. The patent from Anew deals specifically with cognitive decline. Think covid brain. I was in ICU in November 2021, it took almost a year to get out of the fog.

This is the other patent app...

Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho

https://patents.google.com/patent/US20220008519A1/en

There is a patent already issued in Japan to UAB and ICREA. Anew has been given an exclusive licence from UAB and ICREA.

Natural accurance of increased klotho, which is present in 25% of the population, is show to give individuals the cognitive ability of a person with normal levels 10 years younger and increases life expectancy by 20-30%.

Looks like this could be a very valuable patent.